Skip to main content

Advertisement

Log in

Gender influence on ocular manifestations and their outcome in Behcet’s Disease. A long-term follow-up of up to 20 years

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

It is of general belief that males are prone to more frequent, more severe manifestations, and less favorable outcome. We evaluated this hypothesis in ophthalmological manifestations (OM) of Behcet's Disease (BD). Visual acuity (VA), anterior uveitis, posterior uveitis (PU), and retinal vasculitis (RV) were checked, according to Ben Ezra, in 1,515 patients with eye lesions. The data at baseline and last visit were compared. Male/female ratio was 1.2 in the BD registry (6,500 patients) and 1.51 for OM patients (Chi2 = 98.962, p < 0.0001). The patients-year-follow-up was 4,987. All parameters improved significantly from the baseline. Mean VA improved from 4.87 to 5.35 for males (p < 0.0001) and from 5.20 to 5.74 for females (p < 0.0001). Difference between males/females at baseline was not significant (p = 0.60). The mean improvement for males/females was statistically non-significant (p = 0.58). Percent improvement of eyes for males/females was 47.1%/48.8% (p = 0.41). Mean PU improved from 1.83 to 0.71 for males (p < 0.0001) and from 1.66 to 0.49 for females (p < 0.0001). Difference between males/females at baseline was significant (p = 0.01). The mean improvement for males/females was statistically non-significant (p = 0.45). Percent improvement of eyes for males/females was 75.4%/81.0% (p = 0.004). Mean RV improved from 2.05 to 1.16 for males (p < 0.0001) and from 1.97 to 0.99 for females (p < 0.0001). Difference between males/females at baseline was not significant (p = 0.42). The mean improvement for males/females was statistically non-significant (p = 0.47). Percent improvement of eyes for males/females was 62%/64.4% (p = 0.33). Male gender is more prone to ocular manifestations. The severity of lesions at baseline was the same for VA and RV. For PU, the difference was statistically significant, but was not clinically relevant. The therapeutic outcome (mean improvement and percent of improved eyes) was the same for all parameters.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yazici H, Tuzun Y, Pazarli H et al (1984) Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome. Ann Rheum Dis 43:783–789

    Article  PubMed  CAS  Google Scholar 

  2. Yazici H, Tüzün Y, Tanman AB et al (1985) Male patients with Behçet's syndrome have stronger pathergy reactions. Clin Exp Rheumatol 3:137–141

    PubMed  CAS  Google Scholar 

  3. Dilsen N, Konice M, Aral O, Ocal L, Gul A (1993) Risk factors for vital organ involvement in Behcet's Disease. In: Godeau P, Wechsler B (eds) Behcet's Disease. Elsevier Science Publishers B.V, Amsterdam, pp 165–169

    Google Scholar 

  4. Yazici H, Basaran G, Hamuryudan V et al (1996) The ten year mortality in Behcet's syndrome. Br J Rheumatol 35:139–141

    Article  PubMed  CAS  Google Scholar 

  5. Muhaya M, Lightman S, Ikeda E et al (2000) Behçet's disease in Japan and in Great Britain: a comparative study. Ocul Immunol Inflamm 8:141–148

    PubMed  CAS  Google Scholar 

  6. Gurler A, Tursen U, Boyvat A (2000) The evaluation of the clinical findings according to age and sex in 2313 Behcet's patients followed up at the multi-disciplinary Behcet's disease Center in Ankara University School of Medicine. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 84–88

    Google Scholar 

  7. Madanat W, Fayyad F, Verity D, Zureikat H (2000) Influence of sex on behcet's Disease in Jordan. In: Bang D, Lee E, Lee S (eds) behcet's Disease. Design Mecca Publishing, Seoul, pp 90–93

    Google Scholar 

  8. Ames PR, Steuer A, Pap A, Denman AM (2001) Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) 40:652–655

    Article  CAS  Google Scholar 

  9. Davatchi F, Shahram F, Chams H (2003) The influence of gender on the severity and the outcome of ocular lesions in Behçet's disease. Adv Exp Med Biol 528:67–71

    Article  PubMed  CAS  Google Scholar 

  10. Bang D, Oh S, Lee KH, Lee ES, Lee SN (2003) Influence of sex on patients with Behçet's disease in Korea. J Korean Med Sci 18:231–235

    PubMed  Google Scholar 

  11. Janati K, EL Omari K, Benchiki H, Hamdani M, Lakhdar H (2005) Ocular manifestation of Behçet disease (study of 50 patients consulting in dermatology department). Rev Méd Interne 26:771–776

    Article  PubMed  CAS  Google Scholar 

  12. Ricart JM, Todolí J, Vilata JJ et al (2006) Behçet disease: study of 74 patients. Med Clin (Barc) 127:496–499

    Article  Google Scholar 

  13. Düzgün N, Ateş A, Aydintuğ OT, Demir O, Olmez U (2006) Characteristics of vascular involvement in Behçet's disease. Scand J Rheumatol 35:65–68

    Article  PubMed  Google Scholar 

  14. Benamour S, Naji T, Alaoui FZ, El-Kabli H, El-Aidouni S (2006) Neurological involvement in Behçet's disease. 154 cases from a cohort of 925 patients and review of the literature. Neurol (Paris) 162:1084–1090

    CAS  Google Scholar 

  15. Kwon TW, Park SJ, Kim HK, Yoon HK, Kim GE, Yu B (2008) Surgical treatment result of abdominal aortic aneurysm in Behçet's disease. Eur J Vasc Endovasc Surg 35:173–180

    Article  PubMed  Google Scholar 

  16. Yang P, Fang W, Meng Q, Ren Y, Xing L, Kijlstra A (2008) Clinical features of chinese patients with Behçet's disease. Ophthalmology 115:312–318

    Article  PubMed  Google Scholar 

  17. Davatchi F, Sadeghi Abdollahi B, Shahram F et al (2010) Validation of the International Criteria for Behcet's Disease (ICBD) in Iran. Int J Rheum Dis 13:55–60

    Article  PubMed  Google Scholar 

  18. International Team for the Revision of the International Criteria for Behcet's Disease (2006) Revision of the International Criteria for Behcet's Disease (ICBD). Clin Exp Rheumatol 24(Suppl 42):S14–S15

    Google Scholar 

  19. Davatchi F, Shams H, Shahram F et al (2005) Management of ocular manifestations of Behcet's Disease: outcome with cytotoxic drugs. APLAR J Rheumatol 8:119–123

    Article  Google Scholar 

  20. Davatchi F, Shahram F, Chams-Davatchi C et al (2010) How to deal with Behcet's Disease in daily practice. Int J Rheum Dis 13:105–116

    Article  PubMed  Google Scholar 

  21. Ben Ezra D, Forrester JV, Nussenblatt RB, Tabbara K, Timonen P (eds). Uveitis scoring system. Sandoz Ltd and Springer Verlag, Berlin Heidelberg.

  22. Davatchi F, Shams H, Shahram F et al (2009) Longitudinal study of chlorambucil in ocular manifestations of Behcet's Disease. Iranian J Ophthalmol 21:3–14

    Google Scholar 

  23. Davatchi F, Shahram F, Chams-Davatchi C et al (2010) Behcet's Disease in Iran: analysis of 6500 cases. Int J Rheum Dis. doi:10.1111_j.1756-185X.2010.01549

    Google Scholar 

  24. Davatchi F, Shahram F, Chams-Davatchi C et al (2010) Behcet's Disease from East to West. Clin Rheumatol 29:823–833

    Article  PubMed  Google Scholar 

  25. Koh (2000) Ophthalmologic manifestation of Behcet's Disease. In: Bang D, Lee E, Lee S (eds) Behcet's Disease. Design Mecca Publishing, Seoul, pp 90–93

    Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fereydoun Davatchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davatchi, F., Shahram, F., Shams, H. et al. Gender influence on ocular manifestations and their outcome in Behcet’s Disease. A long-term follow-up of up to 20 years. Clin Rheumatol 30, 541–547 (2011). https://doi.org/10.1007/s10067-010-1574-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-010-1574-4

Keywords

Navigation